Innovation Catalyst Funds awarded to seven faculty from October 2025 cycle |
The newly selected research projects span innovative biomedical, medical, and AI technologies aimed at addressing critical healthcare challenges through advanced diagnostic tools, pathogen detection methods, and assistive systems.
|
APPLICATIONS FOR THE NEXT CYCLE OPEN: FEB. 1–28, 2026 |
The Innovation Catalyst Fund will begin accepting applications for the next cycle on February 1. All full-time faculty at Vanderbilt University and Vanderbilt University Medical Center are eligible to apply here.
|
Vanderbilt Institute for Therapeutic Advances launches to redefine drug discovery and biomedical innovation |
Vanderbilt Peabody College empowers workplace education through AI text learning tool |
During our first Entrepreneurship Advisory Council (EAC) meeting of the year, the iTELL AI team pitched their startup for industry feedback. iTELL empowers workplace education through an innovative AI learning tool that transforms static text into interactive learning experiences and tracks learner progress. Learn More
|
Meet the team driving innovation forward |
Its 39-member team supports these efforts across Operations, Corporate Contracts, and Medical Product Support Services, with revenue-generating activities led by Licensing, New Venture Development, and Industry Collaborations.
|
|
|
|
CTTC DIRECTOR OF OPERATIONS |
Donna joined CTTC in March 2024 and is responsible for leading operations and project management activities to optimize the Center's performance and effectiveness. View her leadership profile
|
|
|
| CTTC FY26 Highlights (YTD) |
-
Licenses & Options*: 173
- MTAs: 581
- CDAs: 20
- Invention Disclosures: 152
- U.S. Patents Issued: 31
|
* includes end-user software and materials licenses along with conventional technology licenses
|
|
|
CTTC LUNCH & LEARN: FROM IDEA TO IP FT. ALAN BENTLEY |
March 26, 2026 • 12:00–1:00 p.m. • Vanderbilt Alumni Hall Memorial Room
|
BROCK FAMILY CENTER FOR APPLIED INNOVATION |
Innovator of the Year Lecture: Daniel Fabbri |
March 24, 2026 • 12:00–1:00 p.m. • 208 Light Hall & Online • RSVP HERE
|
|
|
CTTC Licensing: Mike Coyle |
AUTM recently featured Mike's story, where he shared his journey has a Parkinson's researcher, startup co-founder, patent holder, I-Corps instructor, and his role at CTTC managing technology disclosures across about 45 unique therapeutic research programs. Read More
|
Meet the 2025-26 Space-Edge Cohort Participants |
Spanning nanosatellites, metal 3D printing, power generation, and in-space biomanufacturing, this cohort brings together innovators from across the mid-south region to explore and expand the space economy. Read More
|
| Vanderbilt Technologies Earn Patent Protection in January |
12,516,067 – “Antagonists of the Muscarinic Acetylcholine Receptor M4” (Aaron Bender, Matthew Spock, P. Jeffrey Conn, Craig Lindsley)
|
12,521,389 – “New Therapeutic Approach to Lung Disease” (Xin Sun, Jinhao Xu, Lisa Young)
|
12,527,678 – “Wearable Assistance Devices and Methods of Operation” (Karl Zelik, Erik Lamers, Matthew Yandell, Dustin Howser)
|
12,530,538 – “Automated Methods and Systems for Retrieving Information from Scanned Documents” (Michael Ward, Dax Westerman, Ruth Reeves, Jesse Wrenn)
|
12,534,512 – “Human Monoclonal Antibodies to Hantavirus and Methods of Use Therefor” (James Crowe, Jr.)
|
|
|
Center for Technology Transfer and Commercialization
2100 West End Ave. Suite 750
Nashville, TN 37203
vanderbilt.edu/cttc I 615.343.2430
|
2100 West End Ave Suite 750 | Nashville, TN 37203 US
|
|
|
|